J Toxicol Clin Toxicol 2000, 38: 219-220
Clinical trials in patients with metabolic syndrome reveal that L-Carnitine supplementation of 2 g/day for extended periods (25-50 weeks) significantly reduces fasting blood glucose, HbA1c, homeostatic model assessment-insulin resistance (HOMA-IR), inflammatory markers including C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-), and triglyceride levels
Fuentes de la ANMAT revelaron que la autorizacin del frmaco tiene sus especificidades: debe ser prescripto junto con un plan de alimentacin de bajas caloras y un incremento del ejercicio fsico para controlar el peso corporal
This includes liability for any health outcomes, financial decisions, or other actions taken based on the information presented
Injection Site Irritation: Redness, itching, or swelling develops at the point of needle entry
References Kannan, N